HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Magalie Lalanne Selected Research

Uroporphyrinogen III Synthetase (Uroporphyrinogen-III Synthase)

11/2013Therapeutic potential of proteasome inhibitors in congenital erythropoietic porphyria.
7/2012Metabolic correction of congenital erythropoietic porphyria with iPSCs free of reprogramming factors.
8/2010Modeling of congenital erythropoietic porphyria by RNA interference: a new tool for preclinical gene therapy evaluation.
1/2008Effective gene therapy of mice with congenital erythropoietic porphyria is facilitated by a survival advantage of corrected erythroid cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Magalie Lalanne Research Topics

Disease

4Erythropoietic Porphyria (Congenital Erythropoietic Porphyria)
11/2013 - 01/2008
2Hemolytic Anemia
11/2013 - 07/2012
2Erythropoietic Protoporphyria
07/2011 - 09/2003
1Liver Cirrhosis (Hepatic Cirrhosis)
07/2011
1Liver Diseases (Liver Disease)
07/2011
1Liver Failure
07/2011
1Hepatitis
01/2003

Drug/Important Bio-Agent (IBA)

4Uroporphyrinogen III Synthetase (Uroporphyrinogen-III Synthase)IBA
11/2013 - 01/2008
4Heme (Haem)IBA
07/2011 - 09/2003
1Proteasome Endopeptidase Complex (Proteasome)IBA
11/2013
1Busulfan (Busulfex)FDA Link
07/2011
1protoporphyrin IXIBA
07/2011
1Ferrochelatase (Heme Synthetase)IBA
09/2003
1enhanced green fluorescent proteinIBA
01/2003
1Peptide Elongation Factors (Elongation Factor)IBA
01/2003

Therapy/Procedure

1Bone Marrow Transplantation (Transplantation, Bone Marrow)
07/2011